The company attributes its success to strong financial results and gained market share in areas such as trauma and power tools. The company plans to improve its performance in the spine business in 2011 though new product launches and targeted sales efforts.
The company’s growth in the North American market gained momentum through the introduction of new products and the acquisition of Anspach. European sales of Synthes products grew by 14 percent during the fourth quarter.
Read the news release on the 4Q FY 2010 financial report from Synthes.
Read other coverage on Synthes:
– Synthes Acquires U.S. Surgical Tools Manufacturer
– Synthes and Norian Corp. to Pay $23.2M in Fines for Illegally Testing Spinal Bone Cement
– Synthes Reports $907.2M in Net Sales for 3Q FY 2010
